Jump to main content
Jump to site search

Issue 12, 2015
Previous Article Next Article

CO2-switchable drug release from magneto-polymeric nanohybrids

Author affiliations


CO2-responsive well-defined core–shell–corona structure magnetic Fe3O4@SiO2-poly(N,N-dimethylaminoethyl methacrylate) (PDMAEMA) nanocarriers have been developed as efficient drug delivery systems. The hybrid magnetic nanoparticles (MNPs) demonstrated a sandwich structure and highly super-paramagnetic biocompatibility properties as well as gas-responsive behavior. We found that the hydrodynamic radius (Rh) of the magnetic hybrid nanoparticles could be adjusted by alternate CO2/N2 treatment driving a switchable volume transition from contraction to expansion because of the CO2 responsiveness of PDMAEMA. The CO2-triggered protonation of the polymer shell gives rise to an obvious zeta potential change of the nanoparticles. Importantly, the CO2 induced reversible “on–off” transformation makes it possible to perform a dosage release of doxorubicin (DOX) in vitro in a time-controllable manner which is of great significance in controlled drug release. In the presence of CO2, the drug release rate is significantly accelerated, while low drug release could be achieved by removal of CO2 using N2. Moreover, the in vitro cytotoxicity test indicated that the CO2-responsive magnetic nanocarriers have good biocompatibility and could be safely used in living systems.

Graphical abstract: CO2-switchable drug release from magneto-polymeric nanohybrids

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Dec 2014, accepted on 21 Jan 2015 and first published on 22 Jan 2015

Article type: Paper
DOI: 10.1039/C4PY01800A
Citation: Polym. Chem., 2015,6, 2319-2326
  •   Request permissions

    CO2-switchable drug release from magneto-polymeric nanohybrids

    H. Che, M. Huo, L. Peng, Q. Ye, J. Guo, K. Wang, Y. Wei and J. Yuan, Polym. Chem., 2015, 6, 2319
    DOI: 10.1039/C4PY01800A

Search articles by author